Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination
November 21, 2018 07:00 ET
|
Vitality Biopharma, Inc
Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
Vitality Biopharma Receives $8.5 Million Common Stock Financing
October 23, 2018 07:00 ET
|
Vitality Biopharma, Inc
Financing to support company at least into 2020 and for the initiation of multiple Phase 2 clinical trials LOS ANGELES, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
Vitality Biopharma Announces Neural Repair Treatment Patent Filings
October 03, 2018 07:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Scientific Co-Founder to Present Recent Data at CannMed Medical Conference in Los Angeles
September 13, 2018 06:30 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma THC Prodrug VBX-100 Demonstrates Positive Safety Results
August 21, 2018 06:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
June 20, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Sponsors Clinical Research Forum on Ending Opioid Epidemic
June 05, 2018 09:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma to Present at the 8th Annual LD Micro Invitational
May 30, 2018 09:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, May 30, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Discovers and Patents Use of Cannabinoids for C.diff-Associated Diarrhea and Colitis
May 10, 2018 08:30 ET
|
Vitality Biopharma, Inc
- Vitality’s GI-targeted VBX-100 THC compound to be investigated as treatment of recurrent C. difficile infections LOS ANGELES, May 10, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
Vitality Biopharma Launches Canadian Subsidiary Focused on Cannabinoid Genetics R&D
April 05, 2018 09:00 ET
|
Vitality Biopharma, Inc
-Wholly-owned subsidiary to enable access to best available cannabinoid compounds in a federally-compliant manner and facilitate key collaborative research programs LOS ANGELES, April 05, 2018 ...